Der Gynäkologe

, Volume 41, Issue 9, pp 701–713

Neue reproduktionsmedizinische Techniken

CME Weiterbildung • Zertifizierte Fortbildung
  • 77 Downloads

Zusammenfassung

In den letzten Jahren wurden zahlreiche neue reproduktionsmedizinische Techniken entwickelt bzw. optimiert. Zu diesen Techniken gehören die Natural-Cycle-IVF, die „Minimal stimulation IVF“, die In-vitro-Maturation, die Kryokonservierung von unfertilisierten Oozyten und von Ovargewebe sowie die Ovulationsinduktion mit GnRH-Analoga. Diese Techniken ermöglichen in Abhängigkeit von medizinischen Risikokonstellationen oder auch von persönlichen Wünschen der Patientinnen eine zunehmend individualisierte Behandlung. Auch erlauben die neuen Techniken die Erschließung neuer Indikationsgebiete wie die Fertilitätsprotektion bei Krebserkrankungen und die Fertilitätskonservierung als Teil der Lebens- und Karriereplanung der Frau. Des Weiteren wurden in den letzten Jahren bereits etablierte Behandlungsformen wie das Assisted Hatching, die Polkörperanalyse sowie Behandlungen zur Verbesserung der Implantation und der Lutealphase systematisch in großen Studien evaluiert. Sie haben gezeigt, dass die Effektivität dieser Maßnahmen bisher nicht bewiesen werden konnte bzw. zumindest gering ist.

Schlüsselwörter

Natural cycle-IVF In-vitro-Maturation Fertility Preservation Vitrifikation Implantation 

New techniques in reproductive medicine

Abstract

Several new techniques, including natural-cycle in vitro fertilization (IVF), minimal stimulation IVF, in vitro maturation, cryopreservation of unfertilized oocytes and ovarian tissue, and ovulation induction with GnRH analogues, have been developed in reproductive medicine within the last few years. These new techniques allow individualized therapy of the sterile couple. They have also opened new areas in reproductive medicine, such as fertility preservation in cancer patients and in healthy women seeking to slow their“biological clocks.” Other techniques such as assisted hatching, polar body biopsy, and treatments to improve the luteal phase and implantation have been intensively evaluated in large studies. However, these studies have revealed that the efficacy of these techniques remains unproven or is limited.

Keywords

Natural-cycle IVF In vitro maturation Fertility preservation Vitrification Implantation 

Literatur

  1. 1.
    Ata B, Yakin K, Balaban B, Urman B (2008) GnRH-agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH-agonist protocol: a randomized, controlled double blind study. Hum Reprod 23: 668–673PubMedCrossRefGoogle Scholar
  2. 2.
    Beckers NG, Macklon NS, Eijkemans MJ et al. (2003) Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH-Antagonist cotreatment. J Clin Endocrinol Metab 88: 4186–4192PubMedCrossRefGoogle Scholar
  3. 3.
    Cohen J (1991) Assisted hatching of human embryos. J In Vitro Fertil Embryo Transfer 8: 179–190CrossRefGoogle Scholar
  4. 4.
    Fatemi HM, Camus M, Kolibianakis EM et al. (2007) The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril 87: 504–508PubMedCrossRefGoogle Scholar
  5. 5.
    Fatemi HM, Kolibianakis EM, Camus M et al. (2006) Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH-Antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 21: 2628–2632PubMedCrossRefGoogle Scholar
  6. 6.
    Fatemi HM, Popovic-Todorovic B, Papanikolaou E et al. (2007) An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 13: 581–590PubMedCrossRefGoogle Scholar
  7. 7.
    Gelbaya TA, Kyrgiou M, Li TC et al. (2007) Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 13: 357–364PubMedCrossRefGoogle Scholar
  8. 8.
    Griesinger G, Otte S von, Schroer A et al. (2007) Elective cryopreservation of all pronuclear oocytes after GnRH-Agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod 22: 1348–1352PubMedCrossRefGoogle Scholar
  9. 9.
    Khairy M, Banerjee K, El-Toukhy T et al. (2007) Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 88: 822–831PubMedCrossRefGoogle Scholar
  10. 10.
    Kolibianakis EM, Schultze-Mosgau A, Schroer A et al. (2005) A lower ongoing pregnancy rate can be expected when GnRH-Agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH-Antagonists. Hum Reprod 20: 2887–2892PubMedCrossRefGoogle Scholar
  11. 11.
    Ludwig AK, Katalinic A, Steinbicker V et al. (2006) Antenatal care in singleton pregnancies after ICSI as compared to spontaneous conception: data from a prospective controlled cohort study in Germany. Hum Reprod 21: 713–720PubMedCrossRefGoogle Scholar
  12. 12.
    Ludwig M, Diedrich K (2008) Evaluation of an optimal luteal phase support protocol in IVF. Acta Obstet Gynecol Scand 80Google Scholar
  13. 13.
    Lukaszuk K, Liss J, Lukaszuk M, Maj B (2005) Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 83: 1372–1376PubMedCrossRefGoogle Scholar
  14. 14.
    Mastenbroek S, Twisk M, Echten-Arends J van et al. (2007) In vitro fertilization with preimplantation genetic screening. N Engl J Med 357: 9–17PubMedCrossRefGoogle Scholar
  15. 15.
    Ruopp MD, Collins TC, Whitcomb BW, Schisterman EF (2007) Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. Fertil SterilGoogle Scholar
  16. 16.
    Sagoskin AW, Levy MJ, Tucker MJ et al. (2007) Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial. Fertil Steril 87: 283–287PubMedCrossRefGoogle Scholar
  17. 17.
    Seif MM, Edi-Osagie EC, Farquhar C et al. (2006) Assisted hatching on assisted conception (IVF & ICSI) Cochrane Database Syst Rev: CD001894Google Scholar
  18. 18.
    Tesarik J, Hazout A, Mendoza C (2004) Enhancement of embryo developmental potential by a single administration of GnRH-Agonist at the time of implantation. Hum Reprod 19: 1176–1180PubMedCrossRefGoogle Scholar
  19. 19.
    Tesarik J, Hazout A, Mendoza-Tesarik R et al. (2006) Beneficial effect of luteal-phase GnRH-agonist administration on embryo implantation after ICSI in both GnRH-agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 21: 2572–2579PubMedCrossRefGoogle Scholar
  20. 20.
    Ven K van der, Montag M, Ven H van der (2008) Polkörperdiagnostik – ein Schritt in die richtige Richtung? Dtsch Arztebl 105: 190–196Google Scholar
  21. 21.
    Selman H, Angelini A, Barnocchi N et al. (2006) Ongoing pregnancies after vitrification of human oocytes using a combined solution of ethylene glycol and dimethyl sulfoxide. Fertil Steril 86: 997–1000PubMedCrossRefGoogle Scholar
  22. 22.
    Child TJ, Phillips SJ, Abdul-Jalil AK et al. (2002) A comparison of in-vitro-Maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol 100: 665–670PubMedCrossRefGoogle Scholar
  23. 23.
    Wolff M von, Eberhardt I, Strowitzki T (2008) In-vitro-Maturation – a new therapeutic option in polycystic ovary syndrome. Gynakol Geburtshilfliche Rundsch 48: 24–30CrossRefGoogle Scholar
  24. 24.
    Suikkari AM (2008) In-vitro maturation: its role in fertility treatment. Curr Opin Obstet Gynecol 20: 242–248PubMedCrossRefGoogle Scholar
  25. 25.
    Deutsches IVF-Register: http://www.deutsches-ivf-register.de Google Scholar
  26. 26.
    Baart EB, Martini E, Eijkemans MJ et al. (2007) Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod 22: 980–988PubMedCrossRefGoogle Scholar
  27. 27.
    Ubaldi F, Rienzi L, Baroni E et al. (2007) Hopes and facts about mild ovarian stimulation. Reprod Biomed Online 14: 675–681PubMedCrossRefGoogle Scholar
  28. 28.
    Oktay K, Cil AP, Bang H (2006) Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 86: 70–80PubMedCrossRefGoogle Scholar
  29. 29.
    Antinori M, Licata E, Dani G et al. (2007) Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod Biomed Online 14: 72–79PubMedGoogle Scholar
  30. 30.
    Donnez J, Dolmans MM, Demylle D et al. (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: 2020Google Scholar
  31. 31.
    Meirow D, Levron J, Eldar-Geva T et al. (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353: 318–321PubMedCrossRefGoogle Scholar
  32. 32.
    Cha KY, Koo JJ, Ko JJ et al. (1991) Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 55: 109–113PubMedGoogle Scholar
  33. 33.
    Stern C, Chamley L, Norris H et al. (2003) A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 80: 376–383PubMedCrossRefGoogle Scholar
  34. 34.
    Boomsma CM, Keay SD, Macklon NS (2007) Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 24: CD005996Google Scholar
  35. 35.
    Wolff M von, Rösner S, Thöne C et al. (2008) Intravaginal and intracervical application of seminal plasma in in vitro fertilization or intracytoplasmic sperm injection treatment cycles-a double-blind, placebo-controlled, randomized pilot study. Fertil Steril: Epub ahead of printGoogle Scholar
  36. 36.
    Bodri D, Guillén JJ, Galindo A et al. (2008) Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril: Epub ahead of printGoogle Scholar

Copyright information

© Springer Medizin Verlag 2008

Authors and Affiliations

  1. 1.Gynäkologische Endokrinologie und FertilitätsstörungenUniversitäts FrauenklinikHeidelbergDeutschland
  2. 2.Zentrum für Hormon- und Stoffwechselerkrankungen,Reproduktionsmedizin und Pränatale MedizinEndokrinologikum HamburgHamburgDeutschland

Personalised recommendations